Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Down’s syndrome is a genetic condition caused by an error in cell division called ""nondisjunction,"" resulting in an individual having a full or partial extra copy of chromosome 2 ... Read More
-
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to the IgA Nephropathy Foundation, IgA nephropathy is an autoimmune disease that attacks the kidneys and affects blood filtration in the kidneys' small blood vessels. IgA nephropathy occurs when an abn ... Read More
-
Myotonic Dystrophy - Epidemiology Forecast - 2034
Myotonic Dystrophy - Epidemiology Forecast - 2034 Key Highlights DelveInsight's analysis indicates that there were nearly 54,068 diagnosed prevalent cases of myotonic dystrophy in the United States in 2023. Projections suggest that these cases will continue to rise, with anticipated growth reaching ... Read More
-
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 2,718 thousand diagnosed prevalent cases of Parkinson’s disease in the 7MM. Of these, the United States accounted for 45% of the cases, w ... Read More
-
Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034
Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Mild Cognitive Impairment (MCI) was highest in the US among the 7MM, accounting for approximately USD 1,467 million which is further expected to increase by 2034. In 2023, ... Read More
-
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Diamond-Blackfan anemia (DBA) is a rare genetic disorder that primarily affects the bone marrow's ability to produce red blood cells, leading to severe anemia. It is usually diagnosed in infancy or ear ... Read More
-
Alzheimer's Disease Market Insight, Epidemiology And Market Forecast - 2034
Alzheimer's Disease Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Myotonic Dystrophy market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of Myotonic Dystrophy in the 7MM is expected to increase, driven by better di ... Read More
-
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology And Market Forecast - 2034
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Osteogenesis Imperfecta (OI) is a group of genetic disorders that mainly affect the development of bones. People with this condition have bones that break easily, often from little or no tra ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast - 2034
Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast - 2034 Key Highlights DelveInsight’s analyst projects that the Total Diagnosed Prevalent Cases of Chronic Obstructive Pulmonary Disease (COPD) in the 7MM were ~33.3 million in 2023 and these cases are going to increase during the f ... Read More
-
Neuroendocrine Tumors - Market Insight, Epidemiology And Market Forecast - 2034
Neuroendocrine Tumors - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights C3 glomerulopathy (C3G) is a rare kidney disorder characterized by the abnormal buildup of the complement protein C3 in the glomeruli, the filtering units of the kidneys. This excessive complement activati ... Read More
-
Multiple Sclerosis - Pipeline Insight, 2024
Multiple Sclerosis - Pipeline Insight, 2024 DelveInsight’s, “Multiple Sclerosis - Pipeline Insight, 2024” report provides comprehensive insights about 80+ companies and 85+ pipeline drugs in Multiple Sclerosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More
-
Sepsis- Pipeline Insight, 2024
Sepsis- Pipeline Insight, 2024 DelveInsight’s, “Sepsis- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Sepsis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ... Read More
-
Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024
Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024 DelveInsight’s, “Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Wet Age-Related Macular Degeneration (Wet AMD) pipeli ... Read More
-
Dermatomyositis - Epidemiology Forecast - 2034
Dermatomyositis - Epidemiology Forecast - 2034 Key Highlights Dermatomyositis is a rare inflammatory condition characterized by muscle weakness and distinctive skin rashes. It primarily affects adults and children, leading to significant physical disability if left untreated. According to DelveInsig ... Read More
-
Congenital Adrenal Hyperplasia Market Insight, Epidemiology And Market Forecast - 2034
Congenital Adrenal Hyperplasia Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Traumatic Brain Injury market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of Traumatic Brain Injury in the 7MM is expected to increase, ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2034
Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size of congenital adrenal hyperplasia in 2023 was more than USD 20 million in the 7MM, which is expected to grow at a CAGR of ~40% during the forecast period ... Read More
-
Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034
Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034 Key Highlights Idiopathic Membranous Nephropathy (IMN) is a significant type of glomerular disease characterized by the presence of large amounts of protein in the urine (nephrotic syndrome) and is primarily an autoimmune condition. IM ... Read More
-
Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024
Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024 DelveInsight’s, “Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Chronic rhinosinusitis with nasal polyps pipeline landscape. It co ... Read More
-
Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030
Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 Plasma Protein Therapeutics Market by Product (Immunoglobulin, Albumin, Plasma Derived Factor VIII, and Others), Application (Hemophilia, Idiopathic Thrombocytopenic, Primary Immunodeficiencies, and Othe ... Read More
-
Graft versus host disease (GvHD) - Pipeline Insight, 2024
Graft versus host disease (GvHD) - Pipeline Insight, 2024 DelveInsight’s, “Graft versus host disease (GvHD) - Pipeline Insight, 2024” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Graft versus host disease (GVHD) pipeline landscape. It covers the pipeline drug ... Read More
-
Polycystic Ovary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
Polycystic Ovary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for PCPG was estimated to be nearly USD 350 million in 2023, which is expected to show positive growth by 2034. For functioning metastatic PCPG, it is recommended to s ... Read More
-
Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast - 2034
Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast - 2034 Key Highlights In 2023, in the 7MM there were around 1,500,000 diagnosed prevalent cases of NMIBC. In 2023, the highest cases of NMIBC were at stage Ta, followed by T1 and Tis in the United States, while PUN-LMP accounted for ... Read More
-
Opioid Overdose - Pipeline Insight, 2024
Opioid Overdose - Pipeline Insight, 2024 DelveInsight’s, “Opioid Overdose- Pipeline Insight, 2024” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Opioid Overdose pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pro ... Read More
-
22q11.2 Deletion Syndrome - Pipeline Insight, 2024
22q11.2 Deletion Syndrome - Pipeline Insight, 2024 DelveInsight’s, “22q11.2 Deletion Syndrome - Pipeline Insight, 2024” report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in 22q11.2 Deletion Syndrome pipeline landscape. It covers the pipeline drug profiles, including cli ... Read More
-
Lichen Planus- Pipeline Insight, 2024
Lichen Planus- Pipeline Insight, 2024 DelveInsight’s, “Lichen Planus- Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Lichen Planus pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More
Research Assistance
